30.5.2017 15:02 | Business Wire
Westinghouse Receives Award for Commitment to Ukraine
Westinghouse Electric Company was recognized on Wednesday, May 24, for its strong commitment to the economic and democratic development of Ukraine. The award was presented at the Ukraine Gala, hosted by the American Center for a European Ukraine in cooperation with the U.S. - Ukraine Business Council.
“Westinghouse is deeply honored to be recognized by these important U.S.-Ukrainian organizations, which are committed to advancing the national interest of Ukraine. We view our relationship with Ukraine as a partnership, we are not just an investor and supplier,” said Luc Van Hulle, interim president, EMEA Region. “Westinghouse believes there is even more that can be accomplished between Westinghouse and Ukraine to further increase energy security and efficiency, and we look forward to our continued deepening cooperation.”
Westinghouse provides up to 30 percent of Ukraine’s power supply by supplying nuclear fuel.
“With Ukraine advancing diversification in its nuclear fuel supply in cooperation with Westinghouse, it now allows other countries in Europe who remain solely dependent on Russian fuel deliveries to have a strong technical and economically attractive alternative source of fuel for the benefit of their energy security and cost competitiveness,” said Michele DeWitt, senior vice president, Nuclear Fuel.
Westinghouse Electric Company
Sarah Cassella, +1 412-374- 4744
Manager, External Communications
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-IFF/ZOOMESSENCE23.6.2017 14:48 | pressemeddelelse
IFF and ZoomEssence Announce Settlement of Lawsuit
BIOGEN23.6.2017 13:57 | pressemeddelelse
Biogen’s IMRALDI®, an Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive Opinion by Committee for Medicinal Products for Human Use
EUSA-PHARMA23.6.2017 13:38 | pressemeddelelse
EUSA Pharma Receive Positive Opinion from The CHMP For tivozanib For The First-Line Treatment of Advanced Renal Cell Carcinoma In The European Union
CA-GILEAD-SCIENCES,-INC.23.6.2017 13:37 | pressemeddelelse
European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes
SAMSUNG-BIOEPIS23.6.2017 13:32 | pressemeddelelse
Samsung Bioepis' Imraldi® (Adalimumab) Recommended for Approval by European Medicines Agency
MA-BLUEBIRD-BIO23.6.2017 13:02 | pressemeddelelse
bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at European Hematology Association (EHA) Annual Meeting
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum